Article | March 3, 2017

A Bridge Over Troubled Water: The Journey To Serialization Compliance

Source: Ropack Pharma Solutions
A Bridge Over Troubled Water: The Journey To Serialization Compliance

By Nicolas Girard, Ropack Pharma Solutions and Graham Clark, TraceLink

In November 2017, the next phase of the Drug Supply Chain Security Act (DSCSA) goes into effect, which requires pharmaceutical manufacturers to mark their products with a National Drug Code (NDC), serial number, lot number, and expiration date in both machine-readable and human-readable format. If they do not, distributors will not accept their product(s). So what should you expect when it comes to preparing for the next phase of DSCSA, and, most importantly, is it too late?